Blocking of Ang II signaling via ACEIs or ARBs has been shown to inhibit Ang II-mediated endothelial dysfunction and atherosclerosis [129], and ARBs efficiently inhibited vascular remodeling and neointimal hyperplasia after vascular injury [130, 131]. The gene discussed is AGT; the disease is atherosclerosis.